That combination is what makes GLP-1 such a useful drug target, and it is why a hormone first studied for diabetes turned into the most effective weight-management medication class yet developed
However, modern research Read More Protecting Muscle While Treating Obesity: New Protein Targets for Older Adults on GLP-1s Jun 16, 2026 Articles, Diet and Nutrition, Exercise, Geriatric Medicine, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Obesity, Obesity 1,608 views The rise of highly effective GLP-1 receptor agonists and dual incretin therapies has transformed obesity treatment
Desbonnet et al., 2015)
Retatrutide is an investigational triple agonist activating GLP-1, GIP, and glucagon receptors simultaneously, with Phase 2 trials using once-weekly subcutaneous doses of 1 mg to 12 mg